About Xitogen Technologies
Xitogen Technologies is a company based in Suzhou (China) founded in 2013 was acquired by Beckman Coulter in April 2014. Xitogen Technologies operates in a competitive market with competitors including Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Orflo, among others.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Beckman Coulter
(Apr 22, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Xitogen Technologies
Detailed funding history for Xitogen Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Xitogen Technologies
Xitogen Technologies has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical diagnostic products are manufactured for biomedical testing.
|
Locked | Locked | Locked |
Investor details for Xitogen Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xitogen Technologies
Investment portfolio details for Xitogen Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xitogen Technologies
Detailed financials for Xitogen Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xitogen Technologies Comparisons
Peer comparison for Xitogen Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xitogen Technologies
Xitogen Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Orflo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Instruments for life science research are developed and marketed.
|
|
| Locked | Locked | Locked |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| Locked | Locked | Locked |
Screening solutions are provided using bead-based and cell-based assays.
|
|
| Locked | Locked | Locked |
Instrumentation for cell and protein analysis is developed and marketed.
|
|
| Locked | Locked | Locked |
Offers technology for cell analysis, purification, and processing.
|
Detailed competitors of Xitogen Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xitogen Technologies
Complete news archive for Xitogen Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xitogen Technologies
Xitogen Technologies was founded in 2013.
Xitogen Technologies is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Xitogen Technologies was established in 2013 in Suzhou, China, within the biotechnology sector. Research applications for flow cytometry are developed, focusing on detection technologies. The XTG-1600 cytometer, with its compact design, is produced to identify objects in the 100-nanometer range, including viruses, bacteria, microparticles, and cell organelles. Operations center on advancing tools for scientific and medical research in this field.
Xitogen Technologies's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
Xitogen Technologies has 1 investor. Key investors include Beckman Coulter.